Alternatives to Goodfire

Multi-agent research that turns questions into sourced decks, models, and apps

Owkin's K Pro is an autonomous AI scientist agent for biopharma R&D, turning multimodal patient data into drug discovery and clinical trial

Recursion OS pairs automated wet labs with AI models for AI drug discovery at up to 2 million weekly experiments.

Semantic search over 138M papers and 545K clinical trials, with a cited research agent that writes evidence reviews you can defend.

All-in-human AI foundation models for precision neurology — vBx-1.0 predicts brain activity and therapy response from a blood draw.

Fiddler AI is an enterprise AI control plane for agent observability, inline guardrails, and auditable AI governance.

Benchling unifies ELN, LIMS, and AI agents for biotech R&D in one cloud platform.

FDA-cleared AI for cancer pathology: prostate, breast, GI and pan-cancer detection on H&E slides, plus Virchow foundation models for research.

Weights & Biases tracks ML experiments and traces LLM apps so teams ship AI models faster

Dotmatics Luma Agent: agentic AI for regulated R&D that plans, executes, and documents scientific data analysis

OpenCompass (司南) benchmarks LLMs, VLMs, and AI4S models on 100+ open evaluation datasets with dated leaderboards

Open-source AI workbench where a research agent reads papers, writes code, and runs experiments with you.

SapienAI is an open, self-hostable agentic research workspace that unites AI agents with collaborative LaTeX, Typst and Markdown writing.

SciSpace BioMed Agent runs multi-omics, variant prioritization, and drug repurposing analysis from plain-language biomedical prompts.

AI-native pharma company using autonomous agents to find new uses for existing drugs and predict patient drug response

Open-source Python framework that assembles causal and mechanistic models from literature and biological databases.

Evotec is a life-science partner running AI-assisted drug discovery and Just–Evotec Biologics manufacturing.

Nimbus Therapeutics designs highly selective small-molecule drugs for oncology, immunology, and metabolic disease.

Generative AI drug discovery suite spanning target ID, molecule design, biologics and clinical trial prediction.

Wolfram|Alpha answers computable questions with verified results computed from curated data and the Wolfram Language.

Oncology real-world evidence platform combining high-fidelity patient data with AI-assisted cancer research insights.

Iris.ai builds an auditable AI knowledge layer so regulated teams can defend every answer in an audit.

Iktos pairs generative AI with robotic lab automation to compress small-molecule drug discovery.

Renamed: Deep 6 AI was acquired by Tempus AI in March 2025 and its trial matching folded into Tempus.

Physics-based molecular simulation with AI for drug discovery and materials design.

AI form builder that turns every Typeform response into automated GTM workflows and AI-moderated research studies

Quibim turns MRI, CT and PET scans into regulatory-cleared quantitative imaging biomarkers for prostate, brain, liver, breast and lung.

Litmaps turns a single seed paper into a date-versus-citation map for faster literature review.

Tempus pairs tumor DNA/RNA sequencing with AI precision oncology analytics to surface treatment and trial matches

Scite.ai uses Smart Citations to show whether later research supported, contrasted, or merely mentioned a scientific claim.